Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 248 resultater
Tid
Selskap
Tittel
Sektor
Kategori
26 Sep 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Overeenkomst betreffende herkapitalisatie van operationele dochteronderneming door gewaarborgde schuldeisers en liquidatie van beursgenoteerde holdingmaatschappij
20101025 Health Services
Other subject
26 Sep 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis kondigt resultaten H1 2023 aan en geeft een update over de operationele reorganisatie en herkapitalisatie
20101025 Health Services
Other subject
26 Sep 2023
07:00 CEST
BIOCARTIS
Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company
20101025 Health Services
Other subject
26 Sep 2023
07:00 CEST
BIOCARTIS
Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization
20101025 Health Services
Other subject
21 Sep 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023
20101025 Health Services
Other subject
21 Sep 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Webcast 2023 halfjaarresultaten Biocartis op 26 september 2023
20101025 Health Services
Other subject
28 Aug 2023
07:00 CEST
BIOCARTIS
Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders
20101025 Health Services
Other subject
28 Aug 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis stelt nieuwe Medische Adviesraad (MAR) aan van vooraanstaande medische experts
20101025 Health Services
Other subject
24 Aug 2023
07:00 CEST
BIOCARTIS
Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023
20101025 Health Services
Other subject
24 Aug 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis kondigt 2023 Halfjaarresultaten aan op 26 september 2023
20101025 Health Services
Other subject
10 Aug 2023
07:00 CEST
BIOCARTIS
Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform
20101025 Health Services
Other subject
10 Aug 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis collaboreert met Lilly om biomarkertests op het Idylla™ Platform te onderzoeken voor NSCLC patiënten
20101025 Health Services
Other subject
18 Jul 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service Delivery
20101025 Health Services
Other subject
18 Jul 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis benoemt George Cardoza als nieuwe CFO en Hoofd Service Delivery
20101025 Health Services
Other subject
30 Jun 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
20101025 Health Services
Other subject
30 Jun 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
20101025 Health Services
Other subject
20 Jun 2023
17:40 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
20101025 Health Services
Other subject
20 Jun 2023
17:40 CEST
BIOCARTIS
Press release Biocartis Group NV: Disclosure of transparency notification
20101025 Health Services
Other subject
15 Jun 2023
17:15 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis kondigt geplande operationele reorganisatie en kostenverminderingsprogramma aan
20101025 Health Services
Other subject
15 Jun 2023
17:15 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction program
20101025 Health Services
Other subject
08 Jun 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Disclosure of transparency notification
20101025 Health Services
Other subject
08 Jun 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
20101025 Health Services
Other subject
05 Jun 2023
17:40 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis announces resignation CFO
20101025 Health Services
Other subject
05 Jun 2023
17:40 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis kondigt vertrek CFO aan
20101025 Health Services
Other subject
12 May 2023
17:40 CEST
BIOCARTIS
Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023
20101025 Health Services
General meeting / Board Meeting
12 May 2023
17:40 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Resultaten van de Jaarlijkse Algemene Aandeelhoudersvergadering gehouden op 12 mei 2023
20101025 Health Services
General meeting / Board Meeting
09 May 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test
20101025 Health Services
News contracts
09 May 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis en HiloProbe gaan samenwerken op darmkankertest
20101025 Health Services
News contracts
28 Apr 2023
17:40 CEST
BIOCARTIS
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
20101025 Health Services
Change in Capital
28 Apr 2023
17:40 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
20101025 Health Services
Change in Capital
20 Apr 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis rapporteert resultaten eerste kwartaal 2023
20101025 Health Services
Commercial results
20 Apr 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023
20101025 Health Services
Commercial results
11 Apr 2023
22:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis benoemt Roger Moody als nieuwe CEO
20101025 Health Services
Other subject
11 Apr 2023
22:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO
20101025 Health Services
Other subject
11 Apr 2023
07:01 CEST
BIOCARTIS
Persbericht Biocartis Group NV:Oproeping tot de Gewone Algemene Aandeelhoudersvergadering
20101025 Health Services
Corporate life
11 Apr 2023
07:01 CEST
BIOCARTIS
Press release Biocartis Group NV: Invitation to the Annual Shareholders’ Meeting
20101025 Health Services
Corporate life
11 Apr 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual Report
20101025 Health Services
Corporate life
11 Apr 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis kondigt publicatie 2022 jaarverslag aan
20101025 Health Services
Corporate life
04 Apr 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform
20101025 Health Services
Commercial operations
04 Apr 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis en APIS Assay Technologies tekenen samenwerkingsovereenkomst voor de ontwikkeling en commercialisering van een subtyperingstest voor borstkanker op het Idylla™ platform
20101025 Health Services
Commercial operations
31 Mar 2023
17:40 CEST
BIOCARTIS
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
20101025 Health Services
Other subject
31 Mar 2023
17:40 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
20101025 Health Services
Other subject
29 Mar 2023
07:00 CEST
BIOCARTIS
Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023
20101025 Health Services
Other subject
29 Mar 2023
07:00 CEST
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis zal jaarverslag 2022 publiceren op 11 april 2023
20101025 Health Services
Other subject
03 Mar 2023
17:40 CET
BIOCARTIS
Press release Biocartis Group NV: Disclosure of transparency notification
20101025 Health Services
Other subject
03 Mar 2023
17:40 CET
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
20101025 Health Services
Other subject
02 Mar 2023
07:00 CET
BIOCARTIS
Persbericht Biocartis Group NV: Biocartis maakt de goedkeuring bekend van de 510(k) door de US FDA van de Idylla™ MSI Test
20101025 Health Services
Other subject
02 Mar 2023
07:00 CET
BIOCARTIS
Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test
20101025 Health Services
Other subject
28 Feb 2023
17:55 CET
BIOCARTIS
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
20101025 Health Services
Other subject
28 Feb 2023
17:55 CET
BIOCARTIS
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
20101025 Health Services
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
PSI Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Fond
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Global Equity Market - GEM
EuroTLX
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Tech companies Early Metrics reports
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
DataShop
Delayed Data
Historical Data
EOD Index Data
Corporate Actions
Reference Data
Historical Data (raw)
Ecommerce FAQ
Hvor du finner hva